Alterations in Th1/Th2 cytokine concentrations in early neonatal life

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 14, Issue 6, 2003, Pages 407-410

  Protonotariou, E ^a   Malamitsi Puchner, A ^a   Rizos, D ^a   Sarandakou, A ^a   Makrakis, E ^a   Salamalekis, E ^a,b  

^a UNIVERSITY OF ATHENS   (Greece)

^b NONE   (Greece)

Author keywords

Early neonatal period; Interferon ; Interleukin 4; Neonatal serum; Soluble receptor of interleukin 4

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; SOLUBLE INTERLEUKIN 4 RECEPTOR; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BLOOD LEVEL; CESAREAN SECTION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; FEMALE; HUMAN; MALE; MATERNAL BLOOD; NEWBORN; NEWBORN PERIOD; NORMAL HUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; UMBILICAL CORD BLOOD; VAGINAL DELIVERY; BLOOD; CASE CONTROL STUDY; FETUS BLOOD; IMMUNOLOGY; PREGNANCY;

ADULT; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; FETAL BLOOD; HUMANS; INFANT, NEWBORN; INTERFERON TYPE II; INTERLEUKIN-4; MALE; PREGNANCY; RECEPTORS, INTERLEUKIN-4;

EID: 0346880092     PISSN: 14767058     EISSN: None     Source Type: Journal    
DOI: 10.1080/14767050412331312270     Document Type: Article

References (16)

1. Burgio GR, Ugazio AG, Notarangelo LD. Immunology of the neonate. Curr Opin Immunol 1990;2:770-7
2. Berger A. Th1 and Th2 responses: what are they? Br Med J 2000;321:424
3. Vigano A, Esposito S, Arienti D. Differential development of type 1 and type 2 cytokines and β-chemokines in the ontogeny of healthy newborns. Biol Neonate 1999;75:1-8
4. Wakasugi N, Virelizier JL. Defective IFN-γ production in the human neonate. I. Dysregulation rather than intrinsic abnormality. J Immunol 1985;134:167-71
5. Jutel M, Pichler WJ, Skribic D. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-γ secretion in specific allergen stimulated T cell cultures. J Immunol 1995;154:4187-94
6. Savelkoul HFJ. Immune parameters in high risk atopic individuals during early childhood. Am J Respir Crit Care Med 2000;162:5100-4
7. Tang M, Kemp A, Varigos G. IL-4 and interferon-gamma production in children with atopic disease. Clin Exp Immunol 1993;92:120-4
8. Schauer U, Schmitt M, Muller S, et al. Soluble interleukin-4 receptor in atopic children. Int Arch Allergy Immunol 1995; 108:175-82
9. Steinke JW, Borish L. Th2 cytokines and asthma. Interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists. Respir Res 2001;2:66-70
10. Moraes-Pinto MI, Vince GS, Flanagan BF. Localization of IL-4 and IL-4 receptors in the human term placenta, decidua, and amniochorionic membranes. Immunology 1997; 90:87-94
11. Von Freeden U, Zessack N, Van Valen F, et al. Defective interferon gamma production in neonatal T cells is independent of interleukin-2 receptor binding. Pediatr Res 1991;30:270-5
12. White GP, Watt PM, Holt BJ, et al. Differential patterns of methylation of the IFN-gamma promoter at CpG and non-CpG sites underlie differences in IFN-gamma gene expression between human neonatal and adult CD45RO-T cells. J Immunol 2002;168:2820-7
13. Frenkel L, Bryson Y. Ontogeny of phytohemagglutinin-induced gamma interferon by leukocytes of healthy infants and children: evidence of decreased production in infant younger than 2 months of age. Clin Lab Obser 1987;111: 97-100
14. Marsdi L. IL-12 and IFN-γ deficiencies in human neonates. Pediatr Res 2001;49:316-17
15. Bocci V. The neglected organ: bacterial flora has a crucial immunostimulatory role. Perspect Biol Med 1992;35:251-60
16. Buonocore G, De Filippo M, Gioia D, et al. Maternal and neonatal plasma cytokine levels in relation to mode of delivery. Biol Neonate 1995;68:104-10